SynGen Obtains $5,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=266aaac6-80ff-484f-9c5d-3e8e7a25dc35&Preview=1 - Date
4/20/2012 - Company Name
SynGen - Mailing Address
1919 21st Street Sacramento, CA 95811 - Company Description
SynGen enables regenerative cures through innovative engineering. We are in the business of inventing and commercializing products that utilizes single-use sterile plastic cartridge disposables and dedicated, highly automated mechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. - Website
http://www.syngeninc.com - Transaction Type
Venture Equity - Transaction Amount
$5,000,000 - Transaction Round
Series A - Proceeds Purposes
We will use these proceeds to accelerate the commercialization of our SynGen-1000 platform product. - M&A Terms
- Venture Investor
Bay City Capital
